Global Plasma Fractionation Market Growth 2023-2029

Global Plasma Fractionation Market Growth 2023-2029

Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called Plasma Fractionation.
LPI (LP Information)' newest research report, the “Plasma Fractionation Industry Forecast” looks at past sales and reviews total world Plasma Fractionation sales in 2022, providing a comprehensive analysis by region and market sector of projected Plasma Fractionation sales for 2023 through 2029. With Plasma Fractionation sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Plasma Fractionation industry.
This Insight Report provides a comprehensive analysis of the global Plasma Fractionation landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Plasma Fractionation portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Plasma Fractionation market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Plasma Fractionation and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Plasma Fractionation.
The global Plasma Fractionation market size is projected to grow from US$ 27490 million in 2022 to US$ 46760 million in 2029; it is expected to grow at a CAGR of 46760 from 2023 to 2029.
Global Plasma Fractionation key players include Takeda, CSL, Grifols, Octapharma, Kedrion, etc. Global top five manufacturers hold a share about 75%.
North America is the largest market, with a share over 40%, followed by Europe and China, both have a share about 40 percent.
In terms of product, Immune Globulin is the largest segment, with a share about 50%. And in terms of application, the largest application is Immunology, followed by Hematology.
This report presents a comprehensive overview, market shares, and growth opportunities of Plasma Fractionation market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Albumin
Immune Globulin
Coagulation Factor
Others
Segmentation by application
Immunology
Hematology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Key Questions Addressed in this Report
What is the 10-year outlook for the global Plasma Fractionation market?
What factors are driving Plasma Fractionation market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Plasma Fractionation market opportunities vary by end market size?
How does Plasma Fractionation break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.